Jiangwen Shen

Rational design of a minimum nanoplatform for maximizing therapeutic potency: Three birds with one stone.

Linyan Li, Bingchen Zhang, Bangyue Luo, 2022, Journal of colloid and interface science.

Biomimetic nanoparticles: U937 cell membranes based core-shell nanosystems for targeted atherosclerosis therapy.

Mingyue Yang, Pengyu Wu, Jun-Jie Zou, 2021, International journal of pharmaceutics.

Self-assembled micelles of the natural medicine ginsenosides for cancer metastasis therapy

K. Feng, Jing-Wei Shao, Jing Le, 2022, Journal of Industrial and Engineering Chemistry.

Three-pronged attacks by hybrid nanoassemblies involving a natural product, carbon dots, and Cu2+ for synergistic HCC therapy.

Bingchen Zhang, Jing-Wei Shao, Jiangwen Shen, 2023, Journal of colloid and interface science.

Research progress and application of the CRISPR/Cas9 gene-editing technology based on hepatocellular carcinoma

Ruirui Zhao, Bingchen Zhang, Shijing Yu, 2023, Asian journal of pharmaceutical sciences.

Recent research progress based on ferroptosis-related signaling pathways and the tumor microenvironment on it effects.

Jiangwen Shen, Shijing Yu, Lingwu Tong, 2024, European journal of medicinal chemistry.